YO-01027

inquiry

Cat No.

CEI-0205

Description

YO-01027 (Dibenzazepine, DBZ) can inhibit gamma-secretase with IC50 of 2.6 nM.

CAS_No

209984-56-5

Molecular Weight

463.48

Purity

>99%

Storage

2 years at -20 centigrade

Targets

gamma-secretase

Molecular Formula

C26H23F2N3O3

Chemical Name

7-(S)-[N(3,5-difluorophenylacetyl)-L-alaninyl]amino-5-methyl-5,7-dihydro-6H-dibenz[b,d]azepin-6-one

Solubility

DSMO 93 mg/mL Water

In vitro

YO-01027 (Dibenzazepine, DBZ) administered to APPL- or Notch-expressing cells leads to the progressive accumulation of APPL CTF fragments and a decrease in NICD production in a strictly dose-dependent manner.As a gamma-secretase inhibitor, YO-01027 (Dibenzazepine, DBZ) is more potent than CpnE, DAPT, and DFK167.YO-01027 (Dibenzazepine, DBZ) showed no apparent discrimination in blocking APPL and Notch cleavages.

In vivo

In vivo, YO-01027 (Dibenzazepine, DBZ) significantly decrease MCF7 but not MDA-MB-231 tumours and increase latency compared to control mice (18 to 28 days). YO-01027 (Dibenzazepine, DBZ)-treated MCF7 tumours that did form had significantly reduced tumour volumes.

Name:

Email *

Phone:*

Company/Institution:

Country or Region:

Quantity:

Services & Products Interested *

Project Description:

Our Products Cannot Be Used As Medicines Directly For Personal Use.

Products

Online Inquiry